Research suggests that oxytocin acts as a growth modulating agent for breas
t cancer cells. However, the signaling mechanisms responsible for these mod
ulatory effects have not been fully elucidated. In the physiological settin
g oxytocin is known to stimulate contraction of myometrial cells in the ute
rus and myoepithelial cells in the breast by increasing intracellular free
calcium ([Ca2+](i)). The expression of oxytocin receptor mRNA in T-47D brea
st cancer cells, and four additional breast cancer cell lines (BT-549, MCF-
7, MDA-MB- 231, ZR-75-1), was confirmed by RT-PCR analysis. Oxytocin-induce
d changes in [Ca2+](i) in indo-1 AM loaded T-47D breast cancer cells were m
onitored using flow cytometric analysis. In this cell line, oxytocin (0, 1,
10, 100, and 1,000 nM) did not induce a dose-dependent increase in the mea
n 405nm/485nm emission ratio. These results indicate that oxytocin signalin
g in T-47D breast cancer cells does not appear to involve an increase in [C
a2+](i).